This webinar will give you the chance to learn about the activities of ten research infrastructures, all have in common that they provide services in medicine and life sciences.
Some are centered around a specific technique or instrument, others provide education, networking opportunities, access to excellent biobank material, help with research proposals, data management or clinical trials.
After the webinar you will get a contact list so you can get in touch with one or several RIs that you find interesting for follow up questions and to get the desired help.
Program
14:00: Jens Petter Berg, Pro-Dean for research: Welcome
14:05: Leonardo Meza-Zepeda, Norseq: Sequencing
14:15: Tuula Nyman, Joseph Robertson, NAPI: Proteomics
14:25: Kristian Hveem, Oddgeir Holmen, Biobank Norway: Biobank data
14:35: Olav Haraldseth, NORMOLIM: MRI/molecular imaging
14:45: Harald Stenmark, Oddmund Bakke, Nalmin: Microscopy (light imaging)
14:55: Rajeevkumar R. Nair, Mosergruppen: Viral vector tools for neuroscience and biomedicine
15:05: Coffee break
15:10: Johannes Landskron, Nor-Openscreen: Chemical biology, high throughput screening, bioprospecting
15:20: Christine Stansberg, ELIXIR Norway: Life science data and tools
15:30: Anita Kavlie, EATRIS Norway: Translational research, EU funding application support
15:40: Sigrun Sæther, NorCRIN: Clinical trials
15:50: Janna Saarela, NCMM: Conclusions
In our recovery from the COVID-19 pandemic we have experienced how essential cooperation in research and innovation is. Research Infrastructures (RIs) are facilities that provide resources and services for research communities to improve research, innovation and collaboration (international).
An RI can be used beyond research e.g. for education or public services and they may be single-sited, distributed, or virtual. The networks of RIs across Europe provide world-class training for a new generation of researchers and engineers and promote interdisciplinary collaboration.
In the next few years, research infrastructures are expected to act as early adopters of technology, to promote R&D partnerships with industry, to facilitate industrial use of research infrastructures and to stimulate the creation of innovation clusters.